Improvement of sciatic nerve regeneration using laminin-binding human NGF-β

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Sun, Wenjie ^a,b   Sun, Changkai ^c   Zhao, Hui ^c   Lin, Hang ^a   Han, Qianqian ^a   Wang, Jingyu ^c   Ma, Hui ^c   Chen, Bing ^a   Xiao, Zhifeng ^a   Dai, Jianwu ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; HISTIDINE; LAMININ BINDING PROTEIN; NERVE GROWTH FACTOR BETA SUBUNIT; NITRILOTRIACETIC ACID; LAMININ; NERVE GROWTH FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IMMUNOHISTOLOGY; MALE; NERVE CRUSH; NERVE REGENERATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PROTEIN BINDING; RAT; REMYELINIZATION; SCIATIC NERVE; SEQUENCE TAGGED SITE; TARGET CELL; ANIMAL; HUMAN; METABOLISM; MYELIN SHEATH; PHYSIOLOGY;

RATTUS;

ANIMALS; HUMANS; LAMININ; MYELIN SHEATH; NERVE GROWTH FACTOR; NERVE REGENERATION; PROTEIN BINDING; RATS; SCIATIC NERVE;

EID: 67749131220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006180     Document Type: Article

References (48)

1. Kline DG, Kim D, Midha R, Harsh C, Tiel R (1998) Management and results of sciatic nerve injuries: a 24-year experience. J Neurosurg 89: 13-23.
2. Korompilias AV, Payatakes AH, Beris AE, Vekris MD, Afendras GD, et al. (2006) Sciatic and peroneal nerve injuries. Microsurgery 26: 288-294.
3. Navarro X, Vivo M, Valero-Cabre A (2007) Neural plasticity after peripheral nerve injury and regeneration. Prog Neurobiol 82: 163-201.
4. Rosberg HE, Carlsson KS, Dahlin LB (2005) Prospective study of patients with injuries to the hand and forearm: costs, function, and general health. Scand J Plast Reconstr Surg Hand Surg 39: 360-369.
5. Lundborg G (2000) A 25-year perspective of peripheral nerve surgery: evolving neuroscientific concepts and clinical significance. J Hand Surg [Am] 25: 391-414.
6. Levi-Montalcini R (1987) The nerve growth factor: thirty-five years later. Embo J 6: 1145-1154.
7. Petruska JC, Mendell LM (2004) The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett 361: 168-171.
8. Campbell WW (2008) Evaluation and management of peripheral nerve injury. Clin Neurophysiol 119: 1951-1965.
9. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, et al. (1998) Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 51: 695-702.
10. Markowska AL, Koliatsos VE, Breckler SJ, Price DL, Olton DS (1994) Human nerve growth factor improves spatial memory in aged but not in young rats. J Neurosci 14: 4815-4824.
11. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, et al. (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A 102: 3811-3816.
12. Eriksdotter Jonhagen M, Nordberg A, Amberla K, Backman L, Ebendal T, et al. (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9: 246-257.
13. Haller MF, Saltzman WM (1998) Nerve growth factor delivery systems. J Control Release 53: 1-6.
14. Starr PA, Wichmann T, van Horne C, Bakay RA (1999) Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant 8: 37-45.
15. Yurchenco PD, Smirnov S, Mathus T (2002) Analysis of basement membrane self-assembly and cellular interactions with native and recombinant glycoproteins. Methods Cell Biol 69: 111-144.
16. Longo FM, Hayman EG, Davis GE, Ruoslahti E, Engvall E, et al. (1984) Neurite-promoting factors and extracellular matrix components accumulating in vivo within nerve regeneration chambers. Brain Res 309: 105-117.
17. Lander AD, Fujii DK, Reichardt LF (1985) Purification of a factor that promotes neurite outgrowth: isolation of laminin and associated molecules. J Cell Biol 101: 898-913.
18. Martini R (1994) Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 23: 1-28.
19. Fu SY, Gordon T (1997) The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14: 67-116.
20. Stetefeld J, Jenny M, Schulthess T, Landwehr R, Schumacher B, et al. (2001) The laminin-binding domain of agrin is structurally related to N-TIMP-1. Nat Struct Biol 8: 705-709.
21. Mascarenhas JB, Ruegg MA, Winzen U, Halfter W, Engel J, et al. (2003) Mapping of the laminin-binding site of the N-terminal agrin domain (NtA). Embo J 22: 529-536.
22. Pean JM, Menei P, Morel O, Montero-Menei CN, Benoit JP (2000) Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. Biomaterials 21: 2097-2101.
23. Xu X, Yee WC, Hwang PY, Yu H, Wan AC, et al. (2003) Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials 24: 2405-2412.
24. Tuszynski MH, Roberts J, Senut MC, U HS, Gage FH (1996) Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 3: 305-314.
25. Kordower JH, Chen EY, Mufson EJ, Winn SR, Emerich DF (1996) Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons. Neuroscience 72: 63-77.
26. Martinez-Serrano A, Bjorklund A (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 16: 4604-4616.
27. Widmer MS, Gupta PK, Lu L, Meszlenyi RK, Evans GR, et al. (1998) Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials 19: 1945-1955.
28. Tong XJ, Hirai K, Shimada H, Mizutani Y, Izumi T, et al. (1994) Sciatic nerve regeneration navigated by laminin-fibronectin double coated biodegradable collagen grafts in rats. Brain Res 663: 155-162.
29. Chen ZL, Strickland S (2003) Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 163: 889-899.
30. Soussand J, Jahke R, Simon-Assmann P, Stoeckel ME, Schimchowitsch S (2001) Tenascin and laminin function in target recognition and central synaptic differentiation. Neuroreport 12: 1073-1076.
31. Yamada KM (1983) Cell surface interactions with extracellular materials. Annu Rev Biochem 52: 761-799.
32. Koeppen AH (2004) Wallerian degeneration: history and clinical significance. J Neurol Sci 220: 115-117.
33. Stoll G, Muller HW (1999) Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol 9: 313-325.
34. Chaudhry V, Cornblath DR (1992) Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve 15: 687-693.
35. Dellon AL, Mackinnon SE (1989) Selection of the appropriate parameter to measure neural regeneration. Ann Plast Surg 23: 197-202.
36. Martins RS, Siqueira MG, da Silva CF, Plese JP (2006) Correlation between parameters of electrophysiological, histomorphometric and sciatic functional index evaluations after rat sciatic nerve repair. Arq Neuropsiquiatr 64: 750-756.
37. Bain JR, Mackinnon SE, Hunter DA (1989) Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg 83: 129-138.
38. Gu Z, Weidenhaupt M, Ivanova N, Pavlov M, Xu B, et al. (2002) Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies. Protein Expr Purif 25: 174-179.
39. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
40. Finnis ML, Gibson MA (1997) Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen. J Biol Chem 272: 22817-22823.
41. Sun W, Lin H, Chen B, Zhao W, Zhao Y, et al. (2007) Promotion of peripheral nerve growth by collagen scaffolds loaded with collagen-targeting human nerve growth factor-beta. J Biomed Mater Res A 83: 1054-1061.
42. Matsushita O, Jung CM, Minami J, Katayama S, Nishi N, et al. (1998) A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase. J Biol Chem 273: 3643-3648.
43. Wilshaw SP, Kearney JN, Fisher J, Ingham E (2006) Production of an acellular amniotic membrane matrix for use in tissue engineering. Tissue Eng 12: 2117-2129.
44. Lin H, Chen B, Wang B, Zhao Y, Sun W, et al. (2006) Novel nerve guidance material prepared from bovine aponeurosis. J Biomed Mater Res A 79: 591-598.
45. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424-2428.
46. Shih A, Laramee GR, Schmelzer CH, Burton LE, Winslow JW (1994) Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for Trk receptor binding and biological activity. J Biol Chem 269: 27679-27686.
47. Rossi L, Corvo R (2002) Retinoic acid modulates the radiosensitivity of head-and-neck squamous carcinoma cells grown in collagen gel. Int J Radiat Oncol Biol Phys 53: 1319-1327.
48. George LT, Myckatyn TM, Jensen JN, Hunter DA, Mackinnon SE (2003) Functional recovery and histomorphometric assessment following tibial nerve injury in the mouse. J Reconstr Microsurg 19: 41-48.